Wolverine Trading, LLC Inovio Pharmaceuticals, Inc. Put Options Transaction History

Wolverine Trading, LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 14, 2023	SELL	$1.41 - $2.5 $47,094 - $83,500	-33,400 Reduced 50.0%	33,400 $52,000
Q3 2022 Nov 14, 2022	BUY	$1.66 - $2.79 $30,876 - $51,894	18,600 Added 38.59%	66,800 $112,000
Q2 2022 Aug 15, 2022	SELL	$1.44 - $3.98 $26,064 - $72,038	-18,100 Reduced 27.3%	48,200 $86,000
Q1 2022 May 16, 2022	SELL	$2.97 - $5.2 $70,389 - $123,240	-23,700 Reduced 26.33%	66,300 $242,000
Q4 2021 Feb 14, 2022	BUY	$4.99 - $7.46 $449,100 - $671,400	90,000 New	90,000 $467,000
Q3 2021 Nov 12, 2021	SELL	$7.16 - $9.69 $1.02 Million - $1.38 Million	-142,000 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$6.23 - $10.03 $4,361 - $7,021	-700 Reduced 0.49%	142,000 $1.34 Million
Q1 2021 May 14, 2021	SELL	$8.81 - $16.96 $623,748 - $1.2 Million	-70,800 Reduced 33.16%	142,700 $1.26 Million
Q4 2020 Feb 12, 2021	BUY	$8.5 - $12.85 $1.81 Million - $2.74 Million	213,500 New	213,500 $1.92 Million
Q3 2020 Nov 13, 2020	SELL	$9.57 - $27.05 $1.4 Million - $3.97 Million	-146,700 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$7.14 - $31.69 $1.05 Million - $4.65 Million	146,700 New	146,700 $4.65 Million

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $494M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.